• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于片段的药物发现中的 NMR 筛选和命中验证。

NMR screening and hit validation in fragment based drug discovery.

机构信息

Spectroscopy and NMR Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

出版信息

Curr Top Med Chem. 2011;11(1):43-67. doi: 10.2174/156802611793611887.

DOI:10.2174/156802611793611887
PMID:20809889
Abstract

Over the past three decades nuclear magnetic resonance spectroscopy has been developed into a mature technique for the characterization of interactions of small molecule ligands with their corresponding protein and nucleic acid receptors. In fact, a significant number of industrial and academic laboratories employ NMR for screening small molecule compound collections for binding to defined macromolecular targets, thus potentially providing initial, low affinity hits for a fragment-based approach in the drug discovery process. NMR is also applied to interrogate hits obtained by high throughput screening using biochemical assays and by virtual screening methods, for their ability to physically interact with the target receptor. In favorable cases a variety of NMR-based methods can also provide essential information to validate the hit, rank the different hits according to affinity, and to structurally analyze the ligand-target complex, thus providing essential information for structure-based optimization and medicinal chemistry. In this review a comprehensive overview of the large variety of NMR methods to study interactions between small molecule ligands and macromolecular receptors is provided, summarizing the physico-chemical bases of the different receptor- and ligand-observed experiments. The application of these methods for compound library screening and hit validation, with special emphasis on their contribution to fragment-based drug discovery strategies, is illustrated by recent examples selected from the literature and work in my laboratory.

摘要

在过去的三十年中,核磁共振波谱已发展成为一种成熟的技术,可用于表征小分子配体与其相应的蛋白质和核酸受体的相互作用。事实上,许多工业和学术实验室都采用 NMR 技术筛选与特定大分子靶标结合的小分子化合物库,从而为药物发现过程中的基于片段的方法提供初步的低亲和力命中。NMR 还用于通过生化测定和虚拟筛选方法来检测高通量筛选获得的命中,以研究它们与靶受体相互作用的能力。在有利的情况下,各种基于 NMR 的方法还可以提供验证命中所需的重要信息,根据亲和力对不同的命中进行排序,并对配体-靶复合物进行结构分析,从而为基于结构的优化和药物化学提供重要信息。在这篇综述中,全面概述了用于研究小分子配体和大分子受体之间相互作用的大量 NMR 方法,总结了不同受体观察和配体观察实验的物理化学基础。通过文献中的最新实例和我实验室的工作,说明了这些方法在化合物库筛选和命中验证中的应用,特别强调了它们对基于片段的药物发现策略的贡献。

相似文献

1
NMR screening and hit validation in fragment based drug discovery.基于片段的药物发现中的 NMR 筛选和命中验证。
Curr Top Med Chem. 2011;11(1):43-67. doi: 10.2174/156802611793611887.
2
Process of Fragment-Based Lead Discovery-A Perspective from NMR.基于片段的先导化合物发现过程——核磁共振视角
Molecules. 2016 Jul 16;21(7):854. doi: 10.3390/molecules21070854.
3
NMR-Fragment Based Virtual Screening: A Brief Overview.NMR 片段虚拟筛选:简介。
Molecules. 2018 Jan 25;23(2):233. doi: 10.3390/molecules23020233.
4
Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.基于核磁共振的片段筛选策略——靶点固定:用于片段命中识别的TINS、STD和SPR方法比较
J Biomol Screen. 2010 Sep;15(8):978-89. doi: 10.1177/1087057110375614.
5
NMR spectroscopy: the swiss army knife of drug discovery.NMR 光谱学:药物发现的瑞士军刀。
J Biomol NMR. 2020 Nov;74(10-11):509-519. doi: 10.1007/s10858-020-00330-0. Epub 2020 Jul 2.
6
NMR characterization of weak interactions between RhoGDI2 and fragment screening hits.利用 NMR 技术对 RhoGDI2 与片段筛选命中物之间的弱相互作用进行表征。
Biochim Biophys Acta Gen Subj. 2017 Jan;1861(1 Pt A):3061-3070. doi: 10.1016/j.bbagen.2016.10.003. Epub 2016 Oct 6.
7
Practical aspects of NMR-based fragment screening.基于核磁共振的片段筛选的实践要点。
Methods Enzymol. 2011;493:219-39. doi: 10.1016/B978-0-12-381274-2.00009-1.
8
Applications of Solution NMR in Drug Discovery.溶液 NMR 在药物发现中的应用。
Molecules. 2021 Jan 22;26(3):576. doi: 10.3390/molecules26030576.
9
Fragment Screening by NMR.NMR 技术的片段筛选
Methods Mol Biol. 2021;2263:247-270. doi: 10.1007/978-1-0716-1197-5_11.
10
Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.利用基于配体和蛋白质的核磁共振光谱法将片段结合剂推进至类先导化合物。
Methods Enzymol. 2011;493:469-85. doi: 10.1016/B978-0-12-381274-2.00018-2.

引用本文的文献

1
Micromolar Concentration Affinity Study on a Benchtop NMR Spectrometer with Secondary C Labeled Hyperpolarized Ligands.使用二次 C 标记的超极化配体在台式核磁共振光谱仪上进行的微摩尔浓度亲和力研究。
ACS Omega. 2025 Jan 24;10(4):3332-3337. doi: 10.1021/acsomega.4c05101. eCollection 2025 Feb 4.
2
Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?基于核磁共振的片段药物发现。成功之处何在,又该如何改进?
Front Mol Biosci. 2022 Feb 18;9:834453. doi: 10.3389/fmolb.2022.834453. eCollection 2022.
3
Applications of Solution NMR in Drug Discovery.
溶液 NMR 在药物发现中的应用。
Molecules. 2021 Jan 22;26(3):576. doi: 10.3390/molecules26030576.
4
NMR as a "Gold Standard" Method in Drug Design and Discovery.NMR 作为药物设计和发现的“金标准”方法。
Molecules. 2020 Oct 9;25(20):4597. doi: 10.3390/molecules25204597.
5
CcpNmr AnalysisScreen, a new software programme with dedicated automated analysis tools for fragment-based drug discovery by NMR.CcpNmr AnalysisScreen,一款新的软件程序,具有专用的自动化分析工具,用于通过 NMR 进行基于片段的药物发现。
J Biomol NMR. 2020 Nov;74(10-11):565-577. doi: 10.1007/s10858-020-00321-1. Epub 2020 Jul 7.
6
Allosteric Regulation of Hsp90α's Activity by Small Molecules Targeting the Middle Domain of the Chaperone.靶向伴侣蛋白中间结构域的小分子对Hsp90α活性的变构调节
iScience. 2020 Feb 21;23(2):100857. doi: 10.1016/j.isci.2020.100857. Epub 2020 Jan 21.
7
Small molecule-based targeting of TTD-A dimerization to control TFIIH transcriptional activity represents a potential strategy for anticancer therapy.基于小分子的 TTD-A 二聚化靶向以控制 TFIIH 转录活性代表了一种潜在的抗癌治疗策略。
J Biol Chem. 2018 Sep 28;293(39):14974-14988. doi: 10.1074/jbc.RA118.003444. Epub 2018 Aug 1.
8
Spin System Modeling of Nuclear Magnetic Resonance Spectra for Applications in Metabolomics and Small Molecule Screening.用于代谢组学和小分子筛选应用的核磁共振波谱的自旋系统建模。
Anal Chem. 2017 Nov 21;89(22):12201-12208. doi: 10.1021/acs.analchem.7b02884. Epub 2017 Nov 7.
9
Solution NMR Spectroscopy in Target-Based Drug Discovery.基于靶点的药物发现中的溶液核磁共振波谱法。
Molecules. 2017 Aug 23;22(9):1399. doi: 10.3390/molecules22091399.
10
SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands.基于表面等离子体共振技术的神经降压素受体1片段筛选产生新型小分子配体。
PLoS One. 2017 May 16;12(5):e0175842. doi: 10.1371/journal.pone.0175842. eCollection 2017.